Latest News

You can find our latest news below

18 Dec, 2018
We would like to wish you immense happiness during this holiday season and throughout the coming year.
29 Nov, 2018
We have included three new anti-CPV antibodies to our offering. These new MAbs work well in different pair combinations demonstrating high sensitivity in sandwich immunoassays.
27 Nov, 2018
We will be present at the VMX: Veterinary Meeting & Expo, Orlando during January 19-23.
31 Oct, 2018
Serum amyloid A is used as an inflammatory marker in different animals. In cats, it is the only biomarker that shows a rapid and significant response to inflammation.
30 Oct, 2018
We are delighted to let you know that we are sponsoring the EFLM-HyTest Cardiac Marker Award for remarkable scientific work in the field of cardiovascular diseases.
22 Oct, 2018
If you or your colleagues will attend the MEDICA 2018 - the World's Leading Medical Forum - from November 12 to 15, in Düsseldorf, Germany, please schedule a meeting with us.
25 Sep, 2018
HyTest supports cancer research and families burdened with the disease
06 Sep, 2018
Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry.
30 Aug, 2018
During the first half of the year, HyTest’s consolidated revenue grew to 14.4 million euros.
29 Aug, 2018
Our latest article on cardiac troponin I was recently published in Clinical Chemistry. Now you can listen...
04 Jul, 2018
Our researchers presented two posters at the Heart Failure Congress 2018
04 Jul, 2018
Watch our presentation of this biomarker to learn more.
11 Jun, 2018
We will be participating the 2018 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on July 31 - August 2 in Chicago.
30 May, 2018
Are you familiar with all of our different clinical areas? Or were you already aware of how many products we are able to manufacture and ship to our customers every year?
30 May, 2018
In high-sensitivity troponin assays, the specificity of the antibodies utilized is of utmost importance. As the clinically relevant concentration of cardiac troponin T is just nanograms per litre, even a minor cross-reactivity of the assay to skeletal troponin T isoforms could result in false positives.
26 Apr, 2018
During the last fiscal year HyTest’s consolidated revenue was 24.1 million euros, which equated to a year-on-year growth of 1.3%. This rate was low due to the exceptionally strong growth experienced in 2016.
24 Apr, 2018
An integral part of research is made up of the articles that are published in peer-reviewed journals. This year, three different studies conducted by our R&D team have already been published...
29 Mar, 2018
We will be closed during the Easter weekend and will be back in the office again on Tuesday.
28 Mar, 2018
NT-proBNP is an established diagnostic and prognostic marker of heart failure (HF), which is a complex clinical syndrome and health problem that is associated with high morbidity and mortality rates.
28 Mar, 2018
HyTest was established in March 1994 and since our very first day we have worked hard on a daily basis to discover the very best solutions for the needs of our customers.

Do you need samples?

We are happy to make you an offer